PIK3CA and head and neck squamous cell carcinoma: The prevalence of PIK3CA mutations in HNSCC HPV (+) (n = 68) and HNSCC HPV (−) (n = 27) was, respectively, 36.8% (n = 25) and 44.4% (n = 12).